Juan Pablo Umana, MD

Appointed
2023

Education & Fellowships

Fellowship - Stanford Univ Med Ctr
Thoracic Surgery
Stanford, CA United States
2002

Residency - New York Presbyterian Hospital, Columbia University Medical Center
General Surgery
NY, NY United States
1999

Medical Education - Colegio Mayor de Nuestra Senora del Rosario
Bogota, Colombia
1989

Professional Highlights

• Created the Latin-American Cardiovascular Surgery Conference in association with the Society of Thoracic Surgeons and European Association for Cardiothoracic Surgery
• Invited to speak at the Mitral Conclave 2023 and for the last two years at the Annual Meeting of the AATS to present our work on mitral valve repair in the setting of mitral annular dysjunction and technique of aortic valve-sparing root replacement with valve reimplantation

Certifications

• Thoracic & Cardiac Surgery

Awards & Honors

• Jose Vicente Castro-Silva Medal bestowed by El Rosario University as its highest award to medical doctors for their service to Colombia in the medical field, May 2023
• #WeLove Gala Honoree – Lifelong Commitment to Saving Lives
• Research Grant, Columbia University 
• Recipient, Startup Fund, 1996
• Recipient, Blakemore Research Award, 1997
• Second Place, Resident’s Research Competition, 1997
• Educational Chief Resident
• Department of Surgery, Columbia University School of Medicine, 1998-1999
• Finalist, Samson Resident Prize Competition
• Western Thoracic Surgical Association, 2001

Innovations & Patents

• US patent for  Mitraclip

Memberships

• Member of the American Association for Thoracic Surgery
• Member of the Society of Thoracic Surgeons
• Member of the Board of the Heart Valve Society

See publications for Juan Pablo Umana, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/19/2024, Dr. Umana has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Royalty Payments. Dr. Umana receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• Abbott Laboratories

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.